Arterial-ventricular coupling with aging and disease

Paul D Chantler1, Edward G Lakatta

  • 1Division of Exercise Physiology, School of Medicine, West Virginia University Morgantown, WV, USA.

Insights

Aging impacts cardiovascular health by altering arterial-ventricular coupling (E(A)/E(LV)). While resting coupling is maintained, exercise capacity declines with age due to blunted ventricular responses, affecting cardiovascular function and disease progression.

Area of Science:

  • Cardiovascular Physiology
  • Gerontology
  • Biomedical Engineering

Background:

  • Age is the primary risk factor for cardiovascular diseases.
  • Arterial-ventricular coupling (E(A)/E(LV)) is crucial for understanding cardiovascular function, especially with aging and disease.
  • Effective arterial elastance (E(A)) and left ventricular end-systolic elastance (E(LV)) are key components of this coupling.

Purpose of the Study:

  • To investigate the mechanistic insights into cardiovascular changes with aging and disease through arterial-ventricular coupling.
  • To analyze how arterial-ventricular coupling (E(A)/E(LV)) is altered at rest and during exercise in aging and disease states.
  • To understand the implications of these alterations on cardiovascular function and therapeutic interventions.

Main Methods:

  • Analysis of age-associated alterations in arterial structure and function (e.g., stiffness, diameter).
  • Assessment of changes in left ventricular remodeling and function with age.
  • Evaluation of arterial-ventricular coupling (E(A)/E(LV)) at rest and during dynamic exercise in aging and disease cohorts.

Main Results:

  • Resting E(A) and E(LV) increase with age, maintaining optimal energetic efficiency at the expense of mechanical efficacy.
  • This resting coupling is preserved in conditions like hypertension and obesity, despite further increases in E(A) and E(LV).
  • During exercise, aging blunts the reduction in E(A)/E(LV) due to a diminished increase in E(LV), amplifying impairments seen in heart failure.

Conclusions:

  • Age-related changes in arterial and ventricular properties maintain resting arterial-ventricular coupling but impair dynamic exercise responses.
  • Impaired arterial-ventricular coupling with aging and disease contributes to reduced cardiovascular functional capacity.
  • Understanding these interactions is vital for developing effective therapeutic strategies for age-related cardiovascular conditions.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.